BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28196015)

  • 21. Significance of T1a and T1b Carcinoma Arising in Mucinous Cystic Neoplasm of Pancreas.
    Hui L; Rashid A; Foo WC; Katz MH; Chatterjee D; Wang H; Fleming JB; Tamm EP; Wang H
    Am J Surg Pathol; 2018 May; 42(5):578-586. PubMed ID: 29462092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular biomarkers for progression of intraductal papillary mucinous neoplasm of the pancreas.
    Kuboki Y; Shimizu K; Hatori T; Yamamoto M; Shibata N; Shiratori K; Furukawa T
    Pancreas; 2015 Mar; 44(2):227-35. PubMed ID: 25423558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invasive Ductal Carcinoma Arising in Mucinous Cystic Neoplasm of Pancreas: A Case Report.
    Sawai H; Kurimoto M; Koide S; Kiriyama Y; Haba S; Matsuo Y; Morimoto M; Koide H; Kamiya A; Yamao K
    Am J Case Rep; 2019 Feb; 20():242-247. PubMed ID: 30798329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative characteristics and cytological features of 136 histologically confirmed pancreatic mucinous cystic neoplasms.
    Scourtas A; Dudley JC; Brugge WR; Kadayifci A; Mino-Kenudson M; Pitman MB
    Cancer Cytopathol; 2017 Mar; 125(3):169-177. PubMed ID: 27926784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-Wide Somatic Copy Number Alterations and Mutations in High-Grade Pancreatic Intraepithelial Neoplasia.
    Hata T; Suenaga M; Marchionni L; Macgregor-Das A; Yu J; Shindo K; Tamura K; Hruban RH; Goggins M
    Am J Pathol; 2018 Jul; 188(7):1723-1733. PubMed ID: 29684357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.
    Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T
    J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot Project.
    Semaan A; Bernard V; Wong J; Makino Y; Swartzlander DB; Rajapakshe KI; Lee JJ; Officer A; Schmidt CM; Wu HH; Scaife CL; Affolter KE; Nachmanson D; Firpo MA; Yip-Schneider M; Lowy AM; Harismendy O; Sen S; Maitra A; Jakubek YA; Guerrero PA
    Cancer Res Commun; 2023 Oct; 3(10):2062-2073. PubMed ID: 37721516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and Molecular Attributes and Evaluation of Pancreatic Cystic Neoplasm.
    Raut P; Nimmakayala RK; Batra SK; Ponnusamy MP
    Biochim Biophys Acta Rev Cancer; 2023 Jan; 1878(1):188851. PubMed ID: 36535512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
    Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characteristics and biological behaviours of the oncocytic and pancreatobiliary subtypes of intraductal papillary mucinous neoplasms.
    Xiao HD; Yamaguchi H; Dias-Santagata D; Kuboki Y; Akhavanfard S; Hatori T; Yamamoto M; Shiratori K; Kobayashi M; Shimizu M; Fernandez-Del Castillo C; Mino-Kenudson M; Furukawa T
    J Pathol; 2011 Aug; 224(4):508-16. PubMed ID: 21547907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tracking the Clonal Evolution of Adenosquamous Carcinoma, a Rare Variant of Intraductal Papillary Mucinous Neoplasm of the Pancreas.
    Matsuzaka S; Karasaki H; Ono Y; Ogata M; Oikawa K; Tamakawa S; Chiba S; Muraki M; Yokochi T; Funakoshi H; Kono T; Nagashima K; Mizukami Y
    Pancreas; 2016 Jul; 45(6):915-8. PubMed ID: 27295533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma.
    Rezaee N; Barbon C; Zaki A; He J; Salman B; Hruban RH; Cameron JL; Herman JM; Ahuja N; Lennon AM; Weiss MJ; Wood LD; Wolfgang CL
    HPB (Oxford); 2016 Mar; 18(3):236-46. PubMed ID: 27017163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas.
    Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
    Virchows Arch; 2015 Jun; 466(6):665-74. PubMed ID: 25796395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignancy risk factors and prognostic variables of pancreatic mucinous cystic neoplasms in Chinese patients.
    Xia Q; Li F; Min R; Sun S; Han YX; Feng ZZ; Li N
    World J Gastroenterol; 2023 May; 29(20):3119-3132. PubMed ID: 37346158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanism of intraductal papillary mucinous neoplasm and intraductal papillary mucinous neoplasm-derived pancreatic ductal adenocarcinoma.
    Fukuda A
    J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):519-23. PubMed ID: 25900667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA expression signatures in intraductal papillary mucinous neoplasm of the pancreas.
    Lubezky N; Loewenstein S; Ben-Haim M; Brazowski E; Marmor S; Pasmanik-Chor M; Oron-Karni V; Rechavi G; Klausner JM; Lahat G
    Surgery; 2013 May; 153(5):663-72. PubMed ID: 23305591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts.
    Soldini D; Gugger M; Burckhardt E; Kappeler A; Laissue JA; Mazzucchelli L
    J Pathol; 2003 Apr; 199(4):453-61. PubMed ID: 12635136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.
    Yamaguchi J; Mino-Kenudson M; Liss AS; Chowdhury S; Wang TC; Fernández-Del Castillo C; Lillemoe KD; Warshaw AL; Thayer SP
    Gastroenterology; 2016 Dec; 151(6):1232-1244.e10. PubMed ID: 27523981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraductal papillary mucinous neoplasm in a neonate with congenital hyperinsulinism and a de novo germline SKIL gene mutation.
    Jiao Y; Lumpkins K; Terhune J; Hruban RH; Klein A; Kinzler KW; Papadopoulos N; Vogelstein B; Strauch E
    Pancreatology; 2015; 15(2):194-6. PubMed ID: 25464936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Moris D; Damaskos C; Spartalis E; Papalampros A; Vernadakis S; Dimitroulis D; Griniatsos J; Felekouras E; Nikiteas N
    Anticancer Res; 2017 May; 37(5):2185-2194. PubMed ID: 28476781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.